Manufacturer of Controlled Substances; Notice of Application, 2324 [2012-653]

Download as PDF 2324 Federal Register / Vol. 77, No. 10 / Tuesday, January 17, 2012 / Notices Dated: January 6, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application [FR Doc. 2012–679 Filed 1–13–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a), of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 6, 2011 Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule 4–Anilino-N-phenethyl-4-piperidine (8333). Fentanyl (9801) ............................ II II srobinson on DSK4SPTVN1PROD with NOTICES The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Regarding the drug code (8333), the company plans to use this controlled substance to manufacture another controlled substance. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than March 19, 2012. Dated: January 6, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–656 Filed 1–13–12; 8:45 am] Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 12, 2011, Johnson Matthey, Inc., Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania 19428, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Gamma Hydroxybutyric Acid (2010) ................................ Amphetamine (1100) ............ Methylphenidate (1724) ........ Codeine (9050) ..................... Oxycodone (9143) ................ Hydrocodone (9193) ............. Morphine (9300) ................... Thebaine (9333) ................... The company plans to manufacture the listed controlled substances in bulk for sale in bulk to its customers. The Thebaine (9333) will also be used to manufacture other controlled substances in bulk which will also be for sale in bulk to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than March 19, 2012. Dated: January 6, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. 16:12 Jan 13, 2012 Jkt 226001 Schedule Marihuana (7360) ................. Tetrahydrocannabinols (7370) ................................ I II II II II II II II Dated: January 6, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–663 Filed 1–13–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration DEPARTMENT OF JUSTICE Drug Enforcement Administration PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 I I The company plans to manufacture bulk active pharmaceutical ingredients (APIs) for distribution to its customers. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol as a synthetic intermediate. This controlled substance will be further synthesized to bulk manufacture a synthetic THC (7370). No other activity for this drug code is authorized for this registration. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Austin Pharma LLC. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Austin Pharma LLC. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. [FR Doc. 2012–653 Filed 1–13–12; 8:45 am] By Notice dated August 9, 2011, and published in the Federal Register on August 18, 2011, 76 FR 51401, Austin VerDate Mar<15>2010 Drug Schedule Manufacturer of Controlled Substances; Notice of Registration BILLING CODE 4410–09–P Pharma LLC., 811 Paloma Drive, Suite C, Round Rock, Texas 78665–2402, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Registration By Notice dated August 10, 2011, and published in the Federal Register on August 18, 2011, 76 FR 51401, AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to the Drug E:\FR\FM\17JAN1.SGM 17JAN1

Agencies

[Federal Register Volume 77, Number 10 (Tuesday, January 17, 2012)]
[Notices]
[Page 2324]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-653]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 12, 2011, Johnson 
Matthey, Inc., Pharmaceuticals Materials, 900 River Road, Conshohocken, 
Pennsylvania 19428, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                          Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........................               I
Amphetamine (1100)......................................              II
Methylphenidate (1724)..................................              II
Codeine (9050)..........................................              II
Oxycodone (9143)........................................              II
Hydrocodone (9193)......................................              II
Morphine (9300).........................................              II
Thebaine (9333).........................................              II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale in bulk to its customers. The Thebaine (9333) will 
also be used to manufacture other controlled substances in bulk which 
will also be for sale in bulk to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than March 19, 2012.

    Dated: January 6, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-653 Filed 1-13-12; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.